Top Performing Drug of 2021 – Trulicity (February Edition)

Active Ingredient: dulaglutideDosage Forms & Strengths: Injection: 0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3 mg/0.5 mL, 4.5 mg/0.5 mL solution in a single-dose pen Mechanism of Action: GLP-1 receptor agonistFirst Approval: US (Sep 18, 2014), EU (Nov 25, 2014) Revenue Analysis1Trulicity is used for the treatment of type 2 diabetes and to reduce the risk…

BySenior EditorFebruary 22, 2023

INSIGHTS+

Top Performing Drug of 2021 – Imbruvica (January Edition)

Active Ingredient: Ibrutinib Dosage Forms & Strengths: Capsules: 70 mg and 140 mg Tablets: 140 mg, 280 mg, 420 mg, and 560 mg Mechanism of Action: Bruton's tyrosine kinase Inhibitor (BTKi) First Approval: US (13 Nov 2013), EU (Oct 2014)  Revenue AnalysisImbruvica is an oral therapy that inhibits a protein called Bruton's tyrosine kinase. Imbruvica was one…

BySenior EditorJanuary 25, 2023

INSIGHTS+

Top Performing Drug of 2021 – Xarelto (November Edition)

Active Ingredient: rivaroxaban Strength: 2.5 mg, 10 mg, 15 mg, and 20 mg Dosage Form: Tablets Mechanism of Action: Factor Xa inhibitors First Approval: US (1 Jul 2011), EU (30 Sep 2008) Revenue Analysis of Xarelto1 Xarelto has been an important driver of the revenue generated from the cardiovascular portfolio of Janssen. The blood thinner showed an increase of 4%…

BySenior EditorNovember 24, 2022

INSIGHTS+

Top Performing Drug of 2021 – Biktarvy (October Edition)

Active Ingredient: bictegravir, emtricitabine, and tenofovir alafenamideStrength: 50 mg of BIC, 200 mg of FTC, and 25 mg of TAF/ 30 mg of BIC, 120 mg of FTC, and 15 mg of TAFDosage Form: TabletMechanism of Action: HIV reverse transcriptase inhibitorsFirst Approval: US (07 Feb 2018), EU (25 Jun 2018)Revenue1Gilead's HIV drug, Biktarvy has…

BySenior EditorOctober 27, 2022

INSIGHTS+

Top Performing Drug of 2021 – Eliquis (July Edition)

Active Ingredients: ApixabanStrength: 2.5 mg and 5 mgDosage Form: TabletMechanism of Action: Factor Xa inhibitorsFirst Approval: US (Dec 28, 2012), EU (May 18, 2011)Revenue1Eliquis is a leading novel oral anticoagulant of BMS. The revenue for BMS continued to grow due to Eliquis and other recently launched new products. BMS and Pfizer jointly develop and…

BySenior EditorJuly 28, 2022

Top Performing Drug of 2021 – Trulicity (February Edition)

Top Performing Drug of 2021 – Imbruvica (January Edition)

Top Performing Drug of 2021 – Xarelto (November Edition)

Top Performing Drug of 2021 – Biktarvy (October Edition)

Top Performing Drug of 2021 – Eliquis (July Edition)

Contact US

OUR INFORMATION

FOLLOW US